Approve as RI (chemical restraint) as required
The following guide and the medication list has been written to answer the most frequently asked questions by disability service providers. The reporting of chemical
restraint on the Restrictive Intervention Data System (RIDS) is a requirement of the Disability Act 2006. the Senior Practitioner is generally responsible for ensuring that the rights of persons who are subject to restrictive interventions and compulsory treatment are protected and that appropriate standards in relation to restrictive interventions and compulsory treatment are complied with;’ (section 23.2(a)).
This includes chemical restraint as defined in the Act:
‘the use, for the primary purpose of the behavioral control of a person with a disability, of a chemical substance to control or subdue the person but does not include the use of a drug prescribed by a registered medical practitioner for the treatment, or to enable the treatment, of a mental illness or a physical illness or physical condition’.
For further information contact: The Office of the Senior Practitioner 03 90968427 or email seniorpractitioner@dhs.vic.gov.au
Also refer to Practice Advice: Important information about medication prescribed for the primary purpose of the behavioural control of a person with a disability. Version two www.dhs.vic.gov.au/ds/osp
If you would like to receive this publication in an accessible format, please phone 03 9096 8427 using the National Relay Service 13 36 77 if required, or email seniorpractitioner@dhs.vic.gov.au
This document is also available in PDF format on the Internet at www.dhs.vic.gov.au/ds/osp
Ensure all staff are aware of the side effects of all the medications a person is taking (product information can be obtained from your local pharmacist).
Does the person have a diagnosis of mental illness in writing signed by the psychiatrist,
and is the medication prescribed for treatment of this mental illness?
Do not report on RIDS as this medication is for treatment of a mental illness.
Ensure that this person and their medications are reviewed by a psychiatrist
at least once a year. If the person has any behaviours of concern develop a
Behaviour Support Plan (BSP), this will assist consistency and monitoring of
Develop a BSP and report on RIDS. Discuss with the GP if a referral to a specialist medical practitioner (SMP) for diagnosis and medication review is
appropriate. Continue the medication reviews by a SMP on an annual basis or before if necessary.
The community norm is that a GP may diagnose and treat
who is taking psychotropic medications be referred to a
some psychiatric conditions; however the complexities of the
specialist medical practitioner eg.a psychiatrist, paediatrician
person’s disability may require specialist knowledge therefore
or neurologist. All diagnosed medical conditions should be
The Office of the Senior Practitioner is recommending anyone
included in a comprehensive health plan.
Is the medication for treatment of epilepsy? (ask the neurologist)
Do not report on RIDS. This is for treatment of a medical condition; ensure
(medications that depress the central nervous system and
Develop a BSP and report on RIDS. Discuss with the GP if a referral to a SMP for
diagnosis and medication review is appropriate. Continue the medication reviews
on an annual basis or before if necessary.
Is the medication only given for sedation to enable a medical or dental procedure and
Do not report on RIDS this is to enable the treatment of the person with a disability
Develop a BSP and report on RIDS. Discuss with the GP if a referral to a SMP for
diagnosis and medication review is appropriate. Continue the medication reviews on an annual basis or before if necessary.
Does the person have a diagnosis of mental illness in writing signed by the psychiatrist,
and is the medication prescribed for treatment of this mental illness?
Do not report on RIDS this is for treatment of a psychiatric condition. Ensure that
this person and their medications are reviewed by a psychiatrist at least once a
year. If the person has any behaviours of concern develop a BSP.
Develop a BSP and report on RIDS. Discuss with the GP if a referral to a SMP for
diagnosis and medication review is appropriate. Continue the medication reviews
on an annual basis or before if necessary.
Has the person been diagnosed with epilepsy?
Do not report on RIDS this is for treatment of a medical condition. Ensure regular
Develop a BSP and report on RIDS. Discuss with the GP if a referral to a SMP for
diagnosis and medication review is appropriate. Continue the medication reviews on an annual basis or before if necessary.
Does the person have a medical condition diagnosed by a gynaecologist or
endocrinologist to indicate use of this medication?
Do not report on RIDS this is for treatment of a medical condition.
suppression? (to stop the person from having a period)
Develop a BSP and report on RIDS. Ask GP for a referral to a gynaecologist or
endocrinologist for diagnosis and medication review.
Does the person have a diagnosis of mental illness in writing signed by the psychiatrist,
and is the medication prescribed for treatment of this mental illness?
Do not report on RIDS this is for treatment of a psychiatric condition. Ensure that
this person and their medications are reviewed by a psychiatrist at least once a year. If the person has any behaviours of concern develop a BSP.
Develop a BSP and report on RIDS. Discuss with the GP if a referral to a SMP for
diagnosis and medication review is appropriate. Continue the medication reviews on an annual basis or before if necessary.
Appendix 1: Medications reported on RIDS November 2009
Typical antipsychotic medications: Older style medications Benzodiazepines: Medications that depress the central nervous
effective in eliminating or reducing psychotic symptoms such
system and have a calming sleep promoting effect
as delusions, hallucinations and thought disorders. Atypical antipsychotic medications: Newer style medications
effective in eliminating or reducing psychotic symptoms such as
delusions, hallucinations and thought disorders. Intramuscular injections of antipsychotic medications Psychostimulants: Medications used to suppress overactive Menstrual supression: Medications used to stop women having Sedative: Medications used to promote sleep Mood stabalizers: Medications effective in mood disorders such Antidepressants: Medications used in the treatment of depression
as depression or bi-polar illness/some medications used for the
and other mood disorders such as bi-polar illness
treatment of epilepsy have a mood stabilising effect
Hormonal Antiandrogen: Medications used to suppress libido
Department of Human Services, Victoria 2009Authorised by the Victorian Government 50 Lonsdale Street, Melbourne.
Mucosalpreservationiscriticaltosuccessintreatmentofnasalobstructionsecondarytoturbinate hypertrophy. Since hypertrophy is most often secondary to submucosal and non-osseous factors including hypervascularity and submucosal soft tissue excess, BipolarRadiofrequency Turbinate Ablation (RFTA) represents a highly effective, rapid, and well-tolerated techniquethat can be done both i
Falls and Fall Prevention: A Clinical Perspective Elizabeth A. Phelan, MD, MS Associate Professor Medicine / Gerontology and Geriatric Medicine July 10, 2009 Objectives Know and understand: – How often falls occur – Consequences of falls – Why falls occur – How falls may be prevented Definition: coming to rest inadvertently on the ground or lowe